Results 21 to 30 of about 46,198 (239)

Adherence to hydroxyurea, health-related quality of life domains, and patients’ perceptions of sickle cell disease and hydroxyurea: a cross-sectional study in adolescents and young adults

open access: yesHealth and Quality of Life Outcomes, 2017
Background Sickle cell disease (SCD) patients have impaired domains of health-related quality of life (HRQOL). Hydroxyurea is safe and efficacious in SCD; however, adherence is suboptimal, and patients’ perceptions are poorly understood amongst ...
Sherif M. Badawy   +5 more
doaj   +1 more source

Patterns of Hydroxyurea Prescription and Use in Routine Clinical Management of Polycythemia Vera: A Multicenter Chart Review Study

open access: yesTurkish Journal of Hematology, 2020
Objective: This study aimed to evaluate real-life data on patterns of hydroxyurea prescription/use in polycythemia vera (PV). Materials and Methods: This retrospective chart review study included PV patients who had received hydroxyurea therapy for at ...
Yahya Büyükaşık   +20 more
doaj   +1 more source

Do Genetic Polymorphisms Affect Fetal Hemoglobin (HbF) Levels in Patients With Sickle Cell Anemia Treated With Hydroxyurea? A Systematic Review and Pathway Analysis

open access: yesFrontiers in Pharmacology, 2022
Hydroxyurea has long been used for the treatment of sickle cell anemia (SCA), and its clinical effectiveness is related to the induction of fetal hemoglobin (HbF), a major modifier of SCA phenotypes.
Rahyssa Rodrigues Sales   +5 more
doaj   +1 more source

Real-life experience with hydroxyurea in sickle cell disease: A multicenter study in a cohort of patients with heterogeneous descent. [PDF]

open access: yes, 2018
We conducted the first nation-wide cohort study of sickle cell disease (SCD) in Italy, a Southern European country exposed to intense recent flux migration from endemic areas for SCD.
Palazzi G   +11 more
core   +1 more source

Hydroxyurea associated ileocecal valve ulcer: evidence for causality [PDF]

open access: yesIntestinal Research, 2021
Hydroxyurea is an antimetabolite drug that is commonly used in many hematological disorders. Ulcer formation in the gastrointestinal tract is a rare phenomenon associated with this drug.
Thevaraajan Jayaraman   +3 more
doaj   +1 more source

Risk of thrombosis according to need of phlebotomies in patients with polycythemia vera treated with hydroxyurea

open access: yesHaematologica, 2017
Hematocrit control below 45% is associated with a lower rate of thrombosis in polycythemia vera. In patients receiving hydroxyurea, this target can be achieved with hydroxyurea alone or with the combination of hydroxyurea plus phlebotomies.
Alberto Alvarez-Larrán   +28 more
doaj   +1 more source

Studies with Hydroxyurea VII. Hydroxyurea and the Synthesis of Functional Proteins [PDF]

open access: yesJournal of Bacteriology, 1967
Hydroxyurea affected neither the synthesis nor the degradation of bacterial messenger-ribonucleic acid. The proteins made by hydroxyurea-treated cells were structurally intact and fully functional. Since the expression of the lethal action of hydroxyurea requires active protein production, the data indicate that treated cells do not die as the result ...
H S, Rosenkranz   +4 more
openaire   +2 more sources

Photodermatosis secondary to hydroxyurea [PDF]

open access: yesBMJ Case Reports, 2014
A middle aged Southeast-Asian man, recently diagnosed with chronic myeloid leukaemia (Philadelphia positive on FISH), was started on cytoreductive therapy with hydroxyurea due to high leucocyte count (130 000/µL). The patient had no history of using any other drugs simultaneously or in the recent/remote past. He developed a clearly defined erythematous
Uday, Yanamandra   +3 more
openaire   +2 more sources

Hydroxyurea usage and hospitalizations.

open access: yes, 2013
Hydroxyurea usage and hospitalizations.
Fawaz Mzayek (56338)   +6 more
core   +1 more source

Development of Myelodysplastic Syndrome and Acute Myeloid Leukemia 15 Years after Hydroxyurea Use in a patient with sickle Cell Anemia

open access: yesClinical Medicine Insights: Oncology, 2012
We report a 41 year old male with sickle cell disease who developed a myelodysplastic syndrome and acute myeloid leukemia with complex karyotype involving chromosomes 5, 7 and 17 after 15 years of hydroxyurea treatment.
Walid Baz   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy